Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives with an added layer of uncertainty because it’s unclear when and which ...

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

The release of COVID-19 vaccine results days after the 2020 election may have not been a "coincidence" -- and could have been part of an effort by senior Pfizer executives to "deliberately slow ...

Pfizer's early data has spotlighted the future of COVID-19 vaccine distribution, particularly because the company's vaccine presents a potential hurdle: It needs to be stored at around -70 ...

The completion of this study could positively impact Pfizer and BioNTech’s stock performance, as successful results may lead to new vaccine offerings, enhancing their market position. This development ...

Pfizer (NYSE: PFE) was a hot stock during the pandemic, but it has been crashing in recent years. The company's COVID vaccine ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...